Narayana Hrudayalaya Limited has announced a comprehensive schedule for its Q3FY26 financial results disclosure, including a board meeting on February 13, 2026, followed by a management conference call on February 17, 2026. The healthcare services provider has submitted regulatory disclosures to stock exchanges outlining the complete timeline for stakeholder engagement.

Board Meeting Details

The Board of Directors will convene on Friday, February 13, 2026, with the primary agenda being the consideration and approval of unaudited financial results for the quarter ended December 31, 2025.

Management Conference Call

Following the board meeting, the company's management will host a conference call to discuss the financial performance with stakeholders. The call has been scheduled for Tuesday, February 17, 2026, at 03:00 PM IST.

Regulatory Compliance

The company has fulfilled its disclosure obligations under the Securities and Exchange Board of India regulations. The announcements were made pursuant to Regulation 29 and Regulation 30 read with Regulation 50(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Narayana Hrudayalaya Limited has notified both major stock exchanges about the scheduled events:

• BSE Limited: Scrip codes 539551(EQ), 975516 & 976418
• National Stock Exchange of India Limited: Scrip code NH

Information Accessibility

The company has committed to making the financial results disclosure available on its official website at www.narayanahealth.org following the board meeting. This ensures broader accessibility of financial information to stakeholders and maintains transparency in corporate communications.

The latest disclosure regarding the conference call was digitally signed by Sridhar S., Group Company Secretary, Legal & Compliance Officer, on February 11, 2026, demonstrating the company's adherence to digital documentation standards and regulatory timelines.

Narayana Hrudayalaya Limited conducted comprehensive stakeholder meetings on January 19, 2026, to seek approval for the amalgamation scheme involving its subsidiary Meridian Medical Research & Hospital Ltd. The meetings were held pursuant to the Order dated December 02, 2025, passed by the Hon'ble National Company Law Tribunal, Bengaluru Bench.

Meeting Structure and Timeline

The company organized four separate meetings on January 19, 2026, each targeting different stakeholder groups through video conferencing facilities:

Amalgamation Scheme Details

The proposed scheme involves the merger of Meridian Medical Research & Hospital Ltd., acting as the subsidiary and transferor company, with Narayana Hrudayalaya Limited as the transferee company. All meetings focused on a single agenda item: approval of the scheme of arrangement between the two entities.

Meeting Proceedings and Compliance

Shri Murali Ananthasivan, Advocate, appointed as Chairman by the NCLT, presided over all meetings. Shri Sachin Kumar Jhankal served as the appointed Scrutinizer to ensure fair and transparent e-voting processes. The meetings commenced at their scheduled times, with the equity shareholders meeting starting at 12:06 PM after quorum confirmation.

Documentation and Notice Distribution

The company distributed comprehensive documentation to all stakeholders, including:

• Meeting notices and explanatory statements under Sections 230 and 102 of the Companies Act, 2013
• Scheme of arrangement details
• Valuation reports and fairness opinions
• Relevant disclosures as per SEBI regulations
• Other attachments meeting NSE and BSE observation requirements

Voting Arrangements

The company provided dual voting mechanisms to ensure maximum participation:

Meeting Conclusions

The meetings concluded at different times throughout the day, with 15 minutes additional time provided for e-voting after each meeting's proceedings. No shareholders raised queries or sought clarifications regarding the amalgamation scheme during the equity shareholders meeting.

Regulatory Compliance and Next Steps

The company confirmed compliance with the Companies Act, 2013, SEBI Listing Regulations, and applicable MCA circulars. Results of the e-voting process for equity shareholders will be submitted to stock exchanges by January 21, 2026, in the prescribed format under Regulation 44 of SEBI LODR. The Scrutinizer will submit detailed reports to the Chairman, who will incorporate them into the final report for NCLT submission.